Moderna Inc (MRNA)
Debt-to-equity ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 10,901,000 | 13,854,000 | 19,123,000 | 14,145,000 | 2,561,000 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $10,901,000K
= 0.00
The debt-to-equity ratio of Moderna Inc has consistently been 0.00 for the years 2020, 2021, 2022, 2023, and 2024. This indicates that the company has been entirely financed by equity and has not taken on any debt during this period. A low or zero debt-to-equity ratio is generally viewed positively by investors, as it suggests lower financial risk and a stronger financial position. This stability in the debt-to-equity ratio may indicate that Moderna Inc has been managing its capital structure efficiently and is not overly reliant on debt for its operations or growth.
Peer comparison
Dec 31, 2024